Telehealth Improves Quality of Care for Patients with Long-Term Conditions in North East Essex

Tunstall Healthcare GroupNHS North East Essex has launched a telehealth service in partnership with Tunstall Healthcare, which will enhance care provision for patients with long-term conditions, improve their quality of life and help reduce some of the pressure on healthcare providers.

With 4088 bed days taken up with chronic obstructive pulmonary disease (COPD) patients and an average length of stay of seven days per admission, NHS North East Essex has taken the proactive decision to invest in telehealth in order to help reduce emergency admissions and bed days related to chronic heart failure (CHF) and COPD.(1)

Telehealth home monitoring has already helped to reduce the need for patients to make frequent visits to GP surgeries for routine check-ups or nurse home visits, and is enabling patients to self care and manage their condition.

Following the deployment of the telehealth service, over a six month period, the average number of GP visits made by patients had reduced by 66%, the average number of patient hospital attendances or 999 callouts had reduced by 44% and the average number of home visits required had dropped by 19%. This will help to reduce the cost and stress to patients of unscheduled visits to hospital.

In addition, 90% of clinicians involved in the service agreed that telehealth provided assistance with case management as well as assisting with the overall reduction in caseload.

Speaking about the new telehealth initiative, Caroline Westley, project lead at North East Essex PCT said: "By using telehealth, patients can take their own measurements at home that a nurse or GP would normally take, therefore avoiding frequent visits to the surgery or waiting on nurses for home visits.

"Telehealth is providing a vital service to the community by helping to reduce unnecessary hospital admissions, providing patients with the tools to self-care therefore making them feel more empowered and informed about their health and reducing anxiety and exacerbations."

An early evaluation of the telehealth service shows that 100% of patients agreed that the service had helped them better understand their condition and that they felt more involved in their own care, whilst 83% said that it had helped them cope better with their symptoms and had given them a sense of security and peace of mind. 92% of users found the monitors easy to use and would continue to use telehealth in the future.

Patients with COPD and CHF are supplied with telehealth solutions from Tunstall Healthcare, which monitor their blood pressure, oxygen levels, weight and temperature as well as asking a series of health-related questions, on a daily basis. The information is then transmitted via the telephone line where specialist nursing staff triage the data and manage patient health remotely, to ensure timely support is given to patients when needed.

NHS North East Essex is working in partnership with Essex Equipment Services who is providing the telehealth equipment home installation service. The remote monitoring of patients will be evaluated by Colchester Borough Council along with the community matrons and specialist COPD and CHF nurses, who will follow up on patients health status either by phone or a home visit where required.

The telehealth project aims to support over 100 patients during 2010

Related news articles:

1. DMIT

About Tunstall
Tunstall Healthcare Group is the market-leading provider of telehealthcare solutions, with over 2.5 million users globally. Tunstall's solutions support older people and those with long-term needs, to live independently, by effectively managing their health and well-being. Tunstall provides technology, expertise and advice to millions of people enabling them to lead independent more fulfilling lives. For more information on how telehealthcare can improve quality of life, visit www.tunstallhealth.com.

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...